New Hampshire
How Enright v. Eli Lilly & Co. applies in New Hampshire: state-specific rules, key cases, and bar exam notes for Other.
New Hampshire generally adheres to principles of product liability, particularly regarding pharmaceutical companies. The courts in New Hampshire evaluate claims of failure to warn and design defects similarly to how the federal courts approach such claims under strict liability and negligence standards.
In New Hampshire, a pharmaceutical company can be held liable for failure to warn if it is proven that the company did not provide sufficient information about the risks associated with its drug, and this failure resulted in harm to the consumer.
The New Hampshire Supreme Court ruled that a manufacturer is responsible for ensuring that adequate warnings about a product's risks are provided to consumers.
The court determined that evidence of a product's unsafe nature can establish liability if it leads to harm.
Established the necessity for clear labeling and warnings on over-the-counter medications, aligning with failure-to-warn claims.
New Hampshire law mirrors federal standards in product liability cases but allows for some variation based on state-specific statutes that can dictate warning label requirements. Overall, the state courts often apply similar doctrines established in federal precedent, particularly in regard to pharmaceutical liability.
Understanding the principles from Enright and applying them to state-specific cases are crucial for the New Hampshire bar exam, especially in topics related to tort law.